share_log
Moomoo 24/7 ·  Apr 22 07:32
Lexeo Therapeutics Announces In-License Agreement With Cornell University To Expedite Development Of LX2006 For Treatment Of Friedreich Ataxia Cardiomyopathy; Under Agreement, Co. Has Acquired Certain Rights1 Including Rights To Current And Future Data Generated In An Ongoing Investigator-initiated Phase 1A Trial Of AAVrh.10hFXN To Treat Fa Cardiomyopathy
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment